GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Prenetics Global
Shares of Prenetics, a genetic testing company, soared during the pandemic on demand for COVID-19 tests. The current chart reflects the sharp decline in those revenues and the company's search for a new sustainable business model in preventative medicine.
Share prices of companies in the market segment - Medanalysis
Prenetics Global is a genomics and diagnostics company offering COVID-19 tests, as well as disease prevention and personalized healthcare tools. We classify it as a technology innovator in the "Medical Analysis" segment. The chart below shows the dynamics of this rapidly growing sector.
Broad Market Index - GURU.Markets
Prenetics is a global diagnostics and genetic testing company offering a wide range of health and disease prevention tests. It is a component of the GURU.Markets index, and the chart below shows how its stock compares to the overall market trend.
Change in the price of a company, segment, and market as a whole per day
PRE - Daily change in the company's share price Prenetics Global
For biotech company Prenetics Global, the daily price change is an indicator of its inherently high volatility. It reflects the stock's reaction to news about clinical trials and regulatory decisions, serving more than just a number, but as an important variable for the comprehensive risk analysis in System.GURU.Markets formulas.
Daily change in the price of a set of shares in a market segment - Medanalysis
The medical diagnostics sector in which Prenetics Global operates is highly dynamic. This chart reflects the industry's average volatility. It serves as a benchmark for assessing Prenetics' sensitivity to overall trends and competition.
Daily change in the price of a broad market stock, index - GURU.Markets
Prenetics Global is a medical diagnostics company focused on preventative medicine. Its shares respond to innovations in healthcare and changing consumer demand for testing. These industry movements are part of the overall mosaic that shapes the daily market volatility shown below.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Prenetics Global
Prenetics Global's year-over-year performance is a story of adaptation to the post-pandemic world. Following the boom in COVID-19 testing, its 12-month market cap reflects its success in refocusing on genetic testing and preventative medicine, its new long-term growth strategy in the healthcare market.
Annual dynamics of market capitalization of the market segment - Medanalysis
Prenetics Global is a diagnostics and genetic testing company. Following the COVID-19 testing boom, its goal is to prove the resilience of its core business. The chart below shows how the market views its diversified portfolio and the competition in the medical diagnostics sector.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Having experienced an incredible boom and subsequent bust in COVID-19 testing, Prenetics is searching for a new identity. Its stock price reflects not economic cycles, but its ability to find new sources of growth. This chart tells the story of how the company is adapting to life after an unprecedented rise.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Prenetics Global
Prenetics Global offers genetic and diagnostic testing services. Its monthly performance is driven by consumer demand and corporate contracts. Price fluctuations reflect increased testing volumes, new product launches, and partnerships with healthcare systems, which drive its revenue and valuation.
Monthly dynamics of market capitalization of the market segment - Medanalysis
Prenetics Global is a genomics and diagnostic testing company providing tools for personalized medicine and disease prevention. The chart below illustrates the overall dynamics of the medical analysis sector, where genetic testing technologies are opening new horizons in healthcare.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Stocks in medical diagnostics and genetic testing are betting on the future of personalized medicine. The chart below shows the overall risk appetite. Is Prenetics Global moving in sync with the market's growth, or is its success in commercializing tests creating its own trend?
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Prenetics Global
Shares of Prenetics, a genetic testing and diagnostics company, reflect the demand for personalized medicine on a weekly basis. Price movements reflect the launch of new tests, partnerships with clinics, and the overall trend toward a more proactive approach to personal health.
Weekly dynamics of market capitalization of the market segment - Medanalysis
Prenetics Global offers genetic and diagnostic testing services. The dynamics of this sector are closely tied to innovation and the introduction of new tests into medical practice. This chart will show whether Prenetics' weekly share price fluctuations are driven by its own commercial success or reflect general trends in the medical diagnostics industry.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Prenetics is a company in the medical diagnostics sector. Shares of such companies may be less dependent on general economic cycles. This chart will help us understand: are Prenetics shares stuck in a world of clinical trials and the introduction of new tests, or are their stock prices still influenced by overall market conditions?
Market capitalization of the company, segment and market as a whole
PRE - Market capitalization of the company Prenetics Global
Prenetics' market capitalization chart tells the story of a company in the genetic testing and diagnostics space. Its sharp decline after its SPAC IPO reflects the fading hype around COVID testing and the difficulty of building a sustainable business in this space. Its dynamics tell a story of the company's search for new sources of growth after the pandemic boom.
PRE - Share of the company's market capitalization Prenetics Global within the market segment - Medanalysis
Prenetics is a genomics and diagnostics company providing tests for disease detection and personalized health care. Its sector share reflects its market presence and growth potential in preventive medicine. The chart shows its position among other diagnostics companies.
Market capitalization of the market segment - Medanalysis
Prenetics is a company specializing in genetic testing and diagnostics. The chart below shows the total market capitalization of this rapidly growing sector. Its dynamics reflect people's growing interest in their health and ancestry, as well as the need for early and accurate diagnostics.
Market capitalization of all companies included in a broad market index - GURU.Markets
Prenetics Global is a genetic testing and diagnostics company. Its market cap reflects a bet that personalized, DNA-based medicine will become the future of healthcare. Its performance on the overall chart reflects how quickly this futuristic idea is becoming a reality.
Book value capitalization of the company, segment and market as a whole
PRE - Book value capitalization of the company Prenetics Global
Prenetics' balance sheet consists of its laboratories, diagnostic equipment, and capital supporting the development and sale of genetic and COVID-19 tests. This is a tangible, science-intensive foundation for personalized medicine. How has this asset changed since the peak of the pandemic? The chart below tells the story of its transformation.
PRE - Share of the company's book capitalization Prenetics Global within the market segment - Medanalysis
Prenetics is a genetic testing and diagnostics company, which requires high-tech laboratories. The chart shows the share of these tangible assets in the sector, reflecting the physical foundation on which its DNA analysis business is built.
Market segment balance sheet capitalization - Medanalysis
Prenetics is a genetic testing company. It needs labs, but its core assets are technology and data. A book value chart will help you understand how its physical assets compare to its intellectual capital in the field of personalized medicine.
Book value of all companies included in the broad market index - GURU.Markets
Prenetics Global is a leader in genetic testing and diagnostics. The company's book value comes from its high-tech laboratories located around the world and its diagnostic equipment. The chart shows the physical scale of this healthcare company, whose assets help people better understand their health.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Prenetics Global
Prenetics is a diagnostics company. Its value lies not in its laboratories, but in its brand and technology platform. The chart shows the premium the market pays for its leadership in the Asian market and its growth potential in personalized medicine.
Market to book capitalization ratio in a market segment - Medanalysis
Prenetics Global is a genetic testing and diagnostics company. Its value lies in its technology platform and data. The chart shows how much investors believe in its ability to become a leader in personalized medicine, valuing it significantly higher than its laboratory assets.
Market to book capitalization ratio for the market as a whole
Prenetics Global is a genetic testing and diagnostics company. Its value lies in its technology platform, database, and ability to bring new tests to market. This chart shows the market's relationship to tangible assets, but how does it value a company that helps people learn more about their health and ancestry through DNA?
Debts of the company, segment and market as a whole
PRE - Company debts Prenetics Global
Prenetics, a medical diagnostics company, is focusing on efficient capital management after going public. Its financial strategy may include using debt to fund the development of new tests, laboratory expansion, or marketing to increase sales.
Market segment debts - Medanalysis
Prenetics Global provides genetic testing and diagnostics services. The development and commercialization of these tests, as well as data processing, require investment in laboratories and technology. This chart shows how the company finances its activities in the rapidly growing personalized medicine sector.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Prenetics Global
Prenetics Global offers medical diagnostics and genetic testing services. This chart shows how the company finances its research, development of new tests, and international expansion. In the fast-growing field of personalized medicine, debt may reflect an aggressive strategy to capture market share.
Market segment debt to market segment book capitalization - Medanalysis
Prenetics Global offers genetic testing and diagnostic solutions. This chart shows the overall debt burden in the medical analytics sector. It helps understand how companies in this rapidly growing field finance their laboratory capacity and the development of new tests, and how Prenetics manages its capital to scale its business.
Debt to book value of all companies in the market
Prenetics Global offers genetic testing and diagnostics services. It's a technology-based medical company whose value lies in data and innovation. This chart, which reflects the overall market leverage, helps us understand how a business model based on innovation can grow without significant debt, unlike capital-intensive industries.
P/E of the company, segment and market as a whole
P/E - Prenetics Global
This chart for Prenetics Global, a genetic testing and diagnostics company, shows investor assessments of its role in preventive medicine. The multiple reflects expectations for growth in demand for personalized medical solutions and the company's ability to scale its business globally.
P/E of the market segment - Medanalysis
Prenetics' genetic testing is a global market. This chart shows the average valuation for healthcare companies. It helps understand how investors view Prenetics, its transition from COVID-19 testing to a broader range of diagnostic products, and its ability to compete in this market.
P/E of the market as a whole
Prenetics Global is a genomics and diagnostics company offering tests for disease risk detection and personalized medicine. The company experienced growth during the pandemic thanks to its COVID-19 tests. This chart, reflecting overall sentiment in the healthcare sector, helps understand how the market views Prenetics' long-term prospects post-pandemic.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Prenetics Global
Prenetics Global is a genetic and diagnostic testing company. This chart reflects market expectations for demand for its health and disease prevention tests. The trend shows how investors view its transition from COVID-19 testing to a broader range of diagnostic services.
%20P%2FE%20Prenetics%20Global&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Prenetics-Global&v=1772632372779 "Chart of the company's future (projected) P/E Prenetics Global")
Future (projected) P/E of the market segment - Medanalysis
Prenetics Global is a genetic and diagnostic testing company. This chart shows average profitability expectations for the sector. It provides insight into how the market views the company's prospects in a post-pandemic world and its ability to commercialize its technologies for personalized medicine.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Medanalysis&v=1772632372786 "Future (projected) P/E graph of the market segment - Medanalysis")
Future (projected) P/E of the market as a whole
Prenetics Global is a genomics and diagnostics company offering tests for early cancer detection and genetic screening. This chart demonstrates investor appetite for medical innovation. For a company at the forefront of personalized medicine, it reflects the market's willingness to invest in technologies that could transform healthcare.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772632372805 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Prenetics Global
Prenetics Global is a genomic and diagnostic medicine company. Its revenue, presented here, is based on sales of its health and disease prevention tests. The chart illustrates how the trend toward personalized medicine and preventative health care can be transformed into a sustainable business model.
Profit of companies in the market segment - Medanalysis
Prenetics Global is a genomics and diagnostics company offering tests for early disease detection and personalized medicine. Its goal is to make healthcare more proactive. This chart illustrates how the shift from treatment to prevention is creating new profitability in the medical diagnostics sector, where Prenetics' technologies play a key role.
Overall market profit
Prenetics Global is a company specializing in genetic testing and diagnostics. Demand for its services is driven by consumer spending on health and wellness, as well as the integration of its tests into the healthcare system. The company's growth reflects the trend toward personalized medicine, which accelerates during periods of economic stability and rising incomes.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Prenetics Global
Prenetics Global is a genomics and diagnostics company offering health and disease prevention tests. The revenue forecast in this chart reflects analysts' expectations for growth in the personalized medicine market and the company's ability to commercialize its diagnostic products.
%20profit%20of%20the%20company%20Prenetics%20Global&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Prenetics-Global&v=1772632372859 "Graph of future (projected) profit of the company Prenetics Global")
Future (predicted) profit of companies in the market segment - Medanalysis
Prenetics Global is a genetic and diagnostic testing company offering tests for disease risk identification and personalized healthcare. This chart shows the revenue forecast for the healthcare analytics sector, allowing us to assess how Prenetics is capitalizing on the growing trend toward preventative and personalized medicine.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Medanalysis&v=1772632372864 "Graph of future (predicted) profits of companies in a market segment - Medanalysis")
Future (predicted) profit of the market as a whole
Prenetics Global is a genetic testing and diagnostics company. Demand for its services depends on consumer spending on health and wellness. This trend, reflecting overall economic confidence, influences people's willingness to spend on less urgent medical tests, which is a key growth driver for the company.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772632372868 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Prenetics Global
Prenetics Global is a genetic testing and diagnostics company. This chart shows how investors view its revenue following the COVID-19 testing boom. The trend reflects the challenges of finding new sources of growth and the company's belief in the long-term potential of personalized medicine and preventative diagnostics.
P/S market segment - Medanalysis
Prenetics Global is a genetic testing and diagnostics company offering tests for disease risk identification and personalized treatment selection. This chart shows the average price-to-revenue ratio for the healthcare sector. It helps assess how the market perceives Prenetics' technology and its potential in the growing personalized medicine market.
P/S of the market as a whole
Prenetics Global is a genomics and diagnostics company offering tests for disease risk detection and personalized health care. The company is at the forefront of preventative medicine. This overall market valuation chart helps understand how highly investors value companies that are transforming healthcare, making it more proactive.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Prenetics Global
Prenetics Global offers genetic and diagnostic testing solutions. This chart shows the company's valuation relative to its projected future sales. It reflects investor expectations for the growth of the personalized medicine market and the demand for tests that help people manage their health.
%20P%2FS%20Prenetics%20Global&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Prenetics-Global&v=1772632372918 "The graph of the company's future (projected) P/S Prenetics Global")
Future (projected) P/S of the market segment - Medanalysis
Prenetics Global is a genetic testing and diagnostics company offering tests for disease risk identification and personalized medicine. The company's growth depends on the adoption of its diagnostic products. This chart shows market expectations for future sales of its tests compared to other diagnostic companies.
%20P%2FS%20market%20segment%20graph%20-%20Medanalysis&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Medanalysis&v=1772632372922 "Future (projected) P/S market segment graph - Medanalysis")
Future (projected) P/S of the market as a whole
Prenetics Global is a genomics and diagnostics company focused on preventive medicine. Its growth depends on consumer and physician adoption of genetic testing. This general expectations chart for PRE is not a direct driver. Demand for its services is driven by healthcare trends and increased awareness of personalized medicine.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772632372925 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Prenetics Global
This chart shows growth in the genetic testing sector. For Prenetics, it reflects revenue from sales of diagnostic tests and health screening kits that help people take proactive steps to manage their well-being. This growth is driven by increased interest in personalized medicine.
Sales of companies in the market segment - Medanalysis
Prenetics Global is a genetic testing and diagnostics company offering disease prevention solutions. Demand for its services is growing with increasing interest in personalized medicine. This chart shows the growth of the testing market, where Prenetics' products, which help people manage their health, are a key driver.
Overall market sales
Prenetics Global is a company specializing in genetic testing and diagnostics. Demand for its services reflects growing public interest in personalized medicine and personal health. The company's business sits at the intersection of healthcare and consumer technology, demonstrating how innovations in one field create new markets for the masses.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Prenetics Global
Prenetics Global is a genetic testing and diagnostics company offering tests for disease risk identification and personalized health plans. Future sales are driven by growing consumer interest in preventative medicine. This chart reflects expectations for the personalized healthcare market.
%20sales%20of%20the%20company%20Prenetics%20Global&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Prenetics-Global&v=1772632372949 "Schedule of future (projected) sales of the company Prenetics Global")
Future (projected) sales of companies in the market segment - Medanalysis
Prenetics Global is a genomics and diagnostics company. The forecast for the medical analytics sector reflects the growth of personalized medicine. This chart shows the growing demand for tests that help people understand their genetic risks and take proactive measures to maintain their health.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Medanalysis&v=1772632372961 "Schedule of future (projected) sales of companies in the market segment - Medanalysis")
Future (projected) sales of the market as a whole
Prenetics Global is a company specializing in genetic and diagnostic testing. Demand for its services depends on consumer interest in personalized medicine and their health. This pattern of overall economic activity influences discretionary spending. During periods of growth, people are more willing to spend on tests not covered by basic insurance.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772632372969 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Prenetics Global
Prenetics Global is a genetic testing and diagnostics company. Its financial success depends on test sales volumes and laboratory operational efficiency. This chart shows how successfully the company commercializes its diagnostic services, balancing research expenses with growing revenue.
Market segment marginality - Medanalysis
Prenetics Global is a genetic testing and diagnostics company offering disease prevention solutions. Profitability is driven by test sales volume and laboratory process efficiency. This metric reflects the operating profitability of Prenetics' business model in the growing personalized medicine sector.
Market marginality as a whole
Prenetics Global is a genomics and diagnostics company. This chart shows its overall profit margin. Against this backdrop, Prenetics is a story of transitioning from COVID-19 testing to a more sustainable business model based on genetic testing and preventative medicine. Its path to profitability depends on the success of this transformation.
Employees in the company, segment and market as a whole
Number of employees in the company Prenetics Global
Prenetics Global is a genomic diagnostics and diagnostics company. Its staff consists of lab technicians, scientists, and developers. The dynamics in this graph reflect the demand for its services. The explosive growth could be related to COVID-19 testing, while the subsequent stabilization or decline could be due to a refocusing on its core business of genetic testing.
Share of the company's employees Prenetics Global within the market segment - Medanalysis
Prenetics Global is a leading genomics and diagnostic testing company headquartered in Hong Kong. This chart illustrates its scientific and commercial reach. It reflects the significant share of geneticists, laboratory technicians, and bioinformatics specialists Prenetics attracts in Asia to provide its services to millions of users.
Number of employees in the market segment - Medanalysis
Prenetics Global is a genomics and medical diagnostics company. This chart illustrates the growth of personalized medicine. The growing number of geneticists and laboratory technicians demonstrates the growing demand for tests that help people understand their health risks and take preventative measures based on their unique genetic code.
Number of employees in the market as a whole
Prenetics Global offers genetic and diagnostic testing services. Demand for its products is fueled by growing interest in personalized medicine. This trend could develop independently of the overall economic situation, as this chart illustrates. Prenetics' expansion of laboratories and specialist staff is a sign of the growth of this emerging health industry.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Prenetics Global (PRE)
Prenetics Global is a company specializing in genetic testing and diagnostics. Its business is based on scientific research and automated laboratory processes. This chart demonstrates the effectiveness of technology-based medicine. The high capitalization per employee reflects the business's scalability: a single lab with a small team can process thousands of tests.
%20of%20the%20company%20Prenetics%20Global%20(PRE)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Prenetics-Global-PRE&v=1772632373043 "Chart of market capitalization per employee (in thousands of dollars) of the company Prenetics Global (PRE)")
Market capitalization per employee (in thousands of dollars) in the market segment - Medanalysis
Prenetics Global offers genetic and diagnostic testing. It's a high-tech medical company whose core value lies in its scientific foundation and automated laboratories. This chart illustrates its high capital efficiency: a small team can process thousands of tests, leading to a high market valuation per employee.
%20by%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Medanalysis&v=1772632373047 "Market capitalization per employee (in thousands of dollars) by market segment - Medanalysis")
Market capitalization per employee (in thousands of dollars) for the overall market
Prenetics Global is a genetic testing and diagnostics company offering health and COVID-19 tests. This chart reflects its high employee rating, as the business relies on scientific technology and automated lab processes, allowing it to process a large number of tests with a relatively small staff.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772632373059 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Prenetics Global (PRE)
Prenetics Global is a Hong Kong-based genetic testing and diagnostics company. They offer tests for everything from COVID-19 to oncology and newborn screening. It's a knowledge-intensive business. This chart shows how efficient their labs and R&D are. It measures how much profit each lab technician and scientist generates by processing tests and developing new diagnostic products.
%20Chart%20Prenetics%20Global%20(PRE)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Prenetics-Global-PRE&v=1772632373071 "Company Profit Per Employee (in thousands of dollars) Chart Prenetics Global (PRE)")
Profit per employee (in thousands of dollars) in the market segment - Medanalysis
Prenetics Global (PRE) operates in the medical diagnostics and genetic testing industry. This chart shows the industry's benchmark profitability. For PRE, efficiency means a high degree of laboratory automation and a scalable IT platform. They need to process thousands of tests while minimizing manual labor to outperform competitors in terms of profitability per employee.
%20in%20the%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Medanalysis&v=1772632373082 "Chart of profit per employee (in thousands of dollars) in the market segment - Medanalysis")
Profit per employee (in thousands of dollars) for the market as a whole
Prenetics Global (PRE) is a medical diagnostics and genetic testing company. This business requires both robust R&D labs and effective marketing to sell tests to end users. This chart shows how the company balances R&D and commercialization costs, and how profitable each employee in this chain is.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772632373089 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Prenetics Global (PRE)
Prenetics Global provides genetic testing and diagnostics services. This chart shows the efficiency of its laboratory and commercial operations. It measures the test sales generated by each employee. This growth indicates an expansion of the company's services and growing demand for personalized medicine.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Prenetics-Global-PRE&v=1772632373096 "Sales chart per company employee Prenetics Global (PRE)")
Sales per employee in the market segment - Medanalysis
Prenetics Global is a company specializing in genetic testing and diagnostics. Their business consists of shipping test kits and analyzing samples in labs. This metric measures how effectively their teams (lab technicians, marketing, and R&D) generate revenue from each test sold and how their model compares to other diagnostic companies.
Sales per employee for the market as a whole
Prenetics Global is a genomics and medical diagnostics company. They provide testing (including COVID-19 and genetic tests) and telemedicine services. This chart shows the revenue generated by each employee. It reflects the efficiency of their laboratories, technology platform, and commercial success in selling diagnostic services.
Short shares by company, segment and market as a whole
Shares shorted by company Prenetics Global (PRE)
Prenetics Global is a medical diagnostics company offering tests (including genetic and COVID tests) and telemedicine services. This chart shows bearish bets. Bears may expect a sharp decline in revenue after the COVID pandemic ends or believe the consumer genetic testing market is too competitive and low-margin.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Prenetics-Global-PRE&v=1772632373122 "Short Shares Chart for the Company Prenetics Global (PRE)")
Shares shorted by market segment - Medanalysis
Prenetics Global provides genetic testing and diagnostic solutions. This chart shows overall short positions in the medical diagnostics sector. If this chart is high, investors may be concerned about increased competition in the direct-to-consumer testing market or regulatory and reimbursement issues for the entire diagnostics industry.
Shares shorted by the overall market
Prenetics (PRE) is a genetic testing and diagnostics company. It's largely a lifestyle company. When this fear indicator rises, investors anticipate a recession. They fear that consumers will primarily abandon expensive, "optional" medical tests paid for out of pocket.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Prenetics Global (PRE)
Prenetics Global is a Hong Kong-based genetic testing and diagnostics company. The business is subject to country risks and is dependent on demand. A chart above 70 may reflect strong growth or optimism for the region. A range below 30 is often associated with slower growth, competition, or China-related risks.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Prenetics-Global-PRE&v=1772632373178 "RSI 14 indicator chart for the company's stock Prenetics Global (PRE)")
RSI 14 Market Segment - Medanalysis
Prenetics (PRE) — "at-home tests." This diagnostics company (from Hong Kong) soared on COVID tests and is now looking for a new lease on life (genetics). The RSI_14_Seg for "Medanalysis" (diagnostics) shows the "temperature" in this sector. The chart helps us understand: is PRE's decline a post-COVID decline, or is the entire sector oversold?
RSI 14 for the overall market
Prenetics (PRE), a genetic testing company. This chart is an indicator of hype and consumer spending. During the euphoria (and the pandemic), investors were ready to fund the "future of medicine." In the panic, they see fierce competition and falling demand for "optional" tests (DNA, Covid), which is hitting PRE's revenue.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast PRE (Prenetics Global)
Prenetics Global is a diagnostics and healthcare company that, following the COVID-19 pandemic, pivoted to preventative medicine and genetic testing. This chart shows the analysts' average 12-month forecast, reflecting their view on how successful this business pivot will be.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-PRE-Prenetics-Global&v=1772632373199 "A chart showing analyst consensus forecasts for the expected stock price. PRE (Prenetics Global)")
The difference between the consensus estimate and the actual stock price PRE (Prenetics Global)
Prenetics (PRE) is a diagnostics company that, following the COVID testing boom, is attempting to pivot toward R&D and testing for preventative medicine. This chart shows the assessment of this pivot. It measures the gap between the price and the consensus target, reflecting whether analysts believe they can monetize new tests.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-PRE-Prenetics-Global&v=1772632373203 "A chart showing the difference between the consensus forecast and the actual stock price. PRE (Prenetics Global)")
Analyst consensus forecast for stock prices by market segment - Medanalysis
Prenetics is a Hong Kong-based diagnostics company. Having gained recognition for its COVID testing, it is shifting its focus to genetic testing and early cancer detection. This chart shows analysts' overall expectations for the medical testing sector. It reflects whether experts believe the consumer and preventative diagnostics market will grow.
Analysts' consensus forecast for the overall market share price
Prenetics Global is a Hong Kong-based company specializing in genetic testing and diagnostics, known for its COVID-19 tests. This chart shows the overall sentiment of the *global* market. For Prenetics, whose business is searching for a new growth driver after the pandemic, the overall optimism is important, as it reflects risk appetite in Asian markets.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Prenetics Global
Prenetics (PRE) is a healthcare company that began as a leader in direct-to-consumer (DTC) genetic testing in Asia and is now transforming into a preventative healthcare platform (testing, telemedicine). This chart is a summary indicator of their transition. It weighs their ability to monetize their user base and their transition from one-time tests to a subscription model.
AKIMA Market Segment Index - Medanalysis
Prenetics Global is a Hong Kong-based company specializing in genetic testing and diagnostics, best known for its COVID-19 tests. This chart shows the average index for the medical testing sector. It allows investors to assess how Prenetics performs in the competitive diagnostics market.
The AKIM Index for the overall market
Prenetics Global is a genomics and diagnostics company known for its COVID tests and preventative medicine (CircleDNA). This chart, showing the average (global/US) market share, serves as a benchmark. It helps assess how PRE, adapting to a post-pandemic world, compares to overall trends.
